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Abstract
Background: Adhesion barriers have proven to reduce adhesion-related complications in colorectal surgery.
However, barriers are seldom applied. The aim of this study was to determine the cost-effectiveness of adhesion
barriers in colorectal surgery.
Methods: A decision-tree model was developed to compare cost-effectiveness of no adhesion barrier with the use
of an adhesion barrier in open and laparoscopic surgery. Outcomes were incidence of clinical consequences of
adhesions, direct healthcare costs, and incremental cost-effectiveness ratio per adhesion prevented. Deterministic
and probabilistic sensitivity analyses were performed.
Results: Adhesion barriers reduce adhesion incidence and incidence of adhesive small bowel obstruction in open
and laparoscopic surgery. Adhesion barriers in open surgery reduce costs compared to no adhesion barrier ($4376
versus $4482). Using an adhesion barrier in laparoscopic procedures increases costs by $162 ($4482 versus $4320).
The ICER in the laparoscopic cohort was $123. Probabilistic sensitivity analysis showed 66% and 41% probabilities of
an adhesion barrier reducing costs for open and laparoscopic colorectal surgery, respectively.
Conclusion: The use of adhesion barriers in open colorectal surgery is cost-effective in preventing adhesion-related
problems. In laparoscopic colorectal surgery, an adhesion barrier is effective at low costs.
Keywords: Adhesions, Adhesion barrier, Colorectal surgery, Cost-effectiveness
Introduction
Colorectal surgery commonly induces post-operative
adhesion formation, causing a lifelong risk for small
bowel obstruction, female infertility, and chronic vis-
ceral pain [1–4]. Lysis of adhesions at reoperative sur-
gery is associated with inadvertent organ injury,
prolonged operative time, and an increased risk of
post-operative complications and, therefore, higher
costs [5–7]. Several types of adhesion barriers are de-
veloped to prevent post-operative adhesion formation
after abdominal surgery. In a recent systematic review
and meta-analysis on efficacy and safety of adhesion
barriers, hyaluronate carboxymethylcellulose (HA/
CMC) was proven to safely reduce the incidence of
site-specific adhesions and the incidence of re-opera-
tions for adhesive small bowel obstruction after open
colorectal surgery [8]. However, despite the burden of
post-operative adhesions, and the proven benefit of
adhesion barriers, they are seldom applied. In a na-
tionwide survey carried out in the Netherlands in
2009, just 13.4% of surgeons indicated that they had
used any adhesion barrier in the previous year and a
recent follow-up survey did not report much subse-
quent change [9, 10]. Doubts about cost-effectiveness
and the need for adhesion prevention in minimally
invasive surgery may explain the reluctance in the use
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of barriers. Previous cost-effectiveness analyses of ad-
hesion barriers have been based on costs of adhesion-
related re-admission and only concern open surgery
[11, 12]. The efficacy data used were derived from
second-look surgery studies, with a suggested 25–50%
reduction in the number or density of adhesions with
the use of a barrier [11, 12]. In the absence of data
on reduction of adhesion-related readmissions with
the use of a barrier, costs were extrapolated from the
reduction of adhesions. Since publication of these
analyses, evidence on both the burden of adhesions
and the effectiveness of adhesion barriers has in-
creased substantially. Earlier, re-admission for post-
operative small bowel obstruction was considered the
most important complication [13]. New evidence has
clearly shown that difficulty due to dissecting adhe-
sions at repeat abdominal surgery is an even bigger
problem [14]. Moreover, evidence on efficacy of adhe-
sion barriers is no longer limited to adhesion inci-
dence, but comprises clinically relevant endpoints [8].
A decision-tree model was developed in this study for
the use of an adhesion barrier in open colorectal surgery
and laparoscopic colorectal surgery, based on the best
available evidence and considering cost and effect. The
model was designed as an important contribution towards
creating an evidence-based, decision-making protocol on
the use of adhesion barriers in colorectal surgery.
Materials and methods
Decision model
A decision-tree model was designed with Microsoft Of-
fice Excel 2007 that evaluated the strategy of adhesion
prevention with an adhesion barrier in both open and
laparoscopic colorectal surgery. A decision-tree model is
a simplified framework of complex real-life processes
that uses a mathematical method to weigh the risks,
benefits, and costs of clinical strategies [15]. In the
model, two strategies are compared: (1) current clinical
practice, colorectal surgery without the use of an adhe-
sion barrier, and (2) colorectal surgery with the use of
an adhesion barrier (Fig. 1).
Hypothetical cohorts of patients, who have undergone
colorectal surgery (open or laparoscopic), were distributed
over the different pathways in the decision-tree, based on
a set of probabilities that were derived from recently pub-
lished systematic reviews and observational and interven-
tion studies. This allowed the synthesis of evidence and,
thereby, evaluation of the effects and adhesion-related
healthcare costs determined by the treatment decision.
Adhesive small bowel obstruction (ASBO) and difficul-
ties at reoperation were included in the model as potential
consequences of adhesions. Female infertility and chronic
visceral pain were not considered. Risk of infertility is only
an additional reason for the use of an adhesion barrier in
a very small and specific subgroup. Regarding chronic
Fig. 1 Decision-tree model for evaluation of the use of an adhesion barrier in colorectal surgery
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visceral pain, no consistent evidence is available on eti-
ology, incidence, and costs after colorectal surgery [4].
Population
The two target populations consist of patients who
undergo a colorectal resection for a benign or malignant
indication, by either an open or laparoscopic surgical ap-
proach. Colorectal resection is commonly performed for
various indications; the main indication is colorectal
cancer [16]. Colorectal surgery has a relatively high inci-
dence of postoperative adhesion formation [14, 17]. In
2016, in more than 85% of colorectal cancer resections
performed in the Netherlands, laparoscopic techniques
were used [18]. There is recent evidence that laparos-
copy is associated with a lower incidence of adhesions,
particularly to the abdominal wall [19, 20].
Probabilities
In the model, the hypothetical cohorts of patients, who
underwent a colorectal resection, with or without the
use of an adhesion barrier, have different probabilities
for the development of adhesions and subsequent devel-
opment of ASBO, operative or conservative treatment
for ASBO, and adhesiolysis at future repeat surgery.
Probability estimates were derived from recent literature
(see Table 1) [8, 19, 21–32]. PubMed, Embase, and the
Cochrane Library were searched for relevant literature.
Risk ratios for adhesions, ASBO, and operative treatment
of ASBO, with the use of an adhesion barrier, are based
on efficacy data for HA/CMC, as this is the only form of
adhesion barrier with consistent evidence available on
adhesion prevention in visceral surgery. HA/CMC is not
easily applicable in laparoscopic surgery, and evidence
for laparoscopy is lacking. Since there are no alternative
barriers with sound evidence on safety and efficacy in
laparoscopic colorectal surgery, efficacy data of HA/
CMC in open colorectal resection was extrapolated to
the laparoscopic model. The data on incidence of adhe-
sions after open and laparoscopic colorectal surgery
were derived from a recently published multicentre
study [19]. In this study, adhesions after open and lap-
aroscopic colorectal cancer surgery are compared during
surgery for liver metastases.
In a recent systematic review on the value of adhesion
barriers, there were no data on the total incidence of ad-
hesions with the use of HA/CMC [8]. A new search
yielded no additional data on the total incidence of ad-
hesions with the use of HA/CMC. Thus, adhesion inci-
dence with HA/CMC was derived from the incidence of
site-specific adhesions reported (i.e. midline, pelvic adhe-
sions), by only including the anatomical site with the
highest incidence of adhesions from each study [21–23].
The peristomal site was not considered relevant for total
adhesion formation after colorectal surgery. The efficacy
is expressed as a risk ratio of adhesions with the use of
HA/CMC versus no adhesion barrier (RR 0.51 [95% CI
0.43–0.61]).
The probability of ASBO and the probability of sur-
gery for ASBO after colorectal surgery were derived
from an update of the systematic review on the burden
of adhesions after abdominal surgery (1990 to June
2016) [24–31]. Weighted mean follow-up of the studies
was 55.3 months. The probability of future repeat ab-
dominal surgery was derived from a recently published,
prospective cohort of patients, who underwent elective
abdominal surgery [32]. This cohort comprises mainly
patients operated by open approach. Since the incidence
of repeat abdominal surgery is not expected to be sub-
stantially different for patients operated on by laparos-
copy or by open approach, the probability used in both
arms of the model is based on the total cohort. In the
4 years following initial lower gastrointestinal tract sur-
gery, 24% of patients underwent repeat abdominal sur-
gery, including re-operations for ASBO. In the model,
re-operations for ASBO were subtracted from the prob-
ability for repeat surgery to ensure that these re-opera-
tions were not included twice in the model.
Costs
An analysis of adhesion-related costs was performed
with a healthcare perspective, including only direct
healthcare costs for treatment (Table 2). All monetary
values are presented in US dollars (USD/$). Euros were
converted to USD using the exchange rate: 1 Euro to
1.1264 USD.
The mean number of films per patient reported in
two of the three studies on adhesion prevention with
Table 1 Input probabilities in decision-tree model
Open Laparoscopic Adhesion barrier strategy
Variable Probability α β Probability α β Source (reference) RR 95% CI Source (reference)
Patients with adhesions 0.889 80 10 0.623 38 23 [19] 0.51 0.43–0.61 [8, 20–22]
Patients with ASBO 4 years 0.0856 199 2127 0.0663 77 1085 [23–30] 0.68 0.35–1.32 [8, 20–22]
Patients with ASBO treated surgically 0.032 74 2252 0.031 36 1126 [23–30] 0.49 0.28–0.88 [8, 20–22]
Patients with repeat surgery 4 years 0.208 64 200 0.209 64 200 [31]
α patients with event, β patients without event, RR relative risk, CI confidence interval, ASBO adhesive small bowel obstruction
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HA/CMC in colorectal surgery was 3.3 films. The
total costs for HA/CMC were based on the use of 3.3
films and the price of a HA/CMC film in 2016 in the
Netherlands, adding up to a total cost of $629.68 [21,
33]. For sensitivity analysis, a Beta-PERT distribution
was assigned for the number of sheets per patient,
ranging between 2 and 4. Costs of the barrier were
varied according to the Beta-PERT distribution
($382–$763), Table 2.
The healthcare costs of ASBO were derived from a re-
cently performed retrospective analysis of patients ad-
mitted to the Radboud University Medical Center with
the diagnosis of ASBO [34]. The costs for repeat surgery
were derived from a recent, large, cohort study on adhe-
siolysis-related morbidity in abdominal surgery [5].
Data analysis
Data were analysed using mean values for a base case
analysis, to obtain percentages of ASBO, re-operation
for ASBO, patients with adhesions, and direct healthcare
costs for the two strategies, in the 4 years following colo-
rectal surgery. The time frame was based on the mean
4 years’ follow-up periods of the studies, which underlie
the probabilities for ASBO and repeat surgery. If the use
of an adhesion barrier was more effective and more ex-
pensive, incremental cost-effectiveness ratios (ICER)
were calculated to determine the additional costs for one
patient, in whom adhesion formation was prevented. All
presented ICERs are a comparison of the adhesion bar-
rier strategy versus no barrier. If the adhesion barrier
strategy was more effective and reduced costs, this was
considered dominant, and ICERs were not calculated. A
base case analysis was conducted for the two strategies
in open and laparoscopic surgery separately.
Probabilistic sensitivity analysis was performed, using a
Monte Carlo simulation, to explore the impact of uncer-
tainties in the model parameters, as shown in Tables 1
and 2. In the Monte Carlo simulation, 5000 samples
were drawn from the parameter distributions. For each
sample, the hypothetical patient cohort was run through
the model based on these sampled parameters, repre-
senting the uncertainty in the cost-effectiveness estima-
tion. Lognormal distributions were used for all risk
ratios; beta distributions for probabilities and costs were
described by normal distributions. Confidence intervals
were calculated from the probabilistic sensitivity analysis
using the percentile method.
In addition, threshold analyses were conducted for the
costs of the adhesion barrier and the probability of re-
peat surgery, in order to find the maximum values for
these parameters at which the adhesion barrier saves
costs. Deterministic sensitivity analysis was conducted to
explore the influence of deviation in the efficacy of the
different parameters on the cost-effectiveness, assuming
all other variables to be fixed. All parameters were indi-
vidually changed to their lower and upper boundaries of
the 95% confidence intervals. Results of the analysis are
presented in a tornado diagram. Furthermore, a best-
and worst-case scenario was calculated; for the worst-
case scenario, the risk ratios for adhesions, ASBO, and
operative treatment of ASBO were all set to the upper
limit of their confidence interval (Table 1). For the best-
case scenario, all three risk ratios were raised to the
lower limit of their confidence interval.
Results
Base case analysis
With the parameters at their base case values, for the
open colorectal surgery cohort, the adhesion barrier
strategy was both more effective and less expensive than
the no adhesion barrier strategy, whilst in the laparo-
scopic colorectal surgery cohort, the adhesion barrier
strategy was more effective, but more expensive
(Table 3). In open colorectal surgery, use of an adhesion
barrier reduced the incidence of adhesions from 88.9%
(95% CI 81.8–94.5%) to 45.3% (95% CI 37.3–54.6%) and
the incidence of ASBO from 8.6% (95% CI 7.5–9.7%) to
6.2% (95% CI 2.9–11.3%). The expected mean direct
healthcare costs in 4 years after initial open colorectal
surgery were reduced by $106, from $4482 (95% CI
$3074–$6284) per patient in the group without an adhe-
sion barrier to $4376 (95% CI $3140–$5892) in the
group with an adhesion barrier. After laparoscopic colo-
rectal surgery, the incidence of patients with adhesions
was reduced from 62.3% (95% CI 49.9–73.8%) to 31.8%
(95% CI 24.3–40.7%) and the incidence of ASBO from
Table 2 Costs used in the model
Value SD Source (reference)
Costs HA/CMC $630 $382–$763* [20, 32]
ASBO with operative treatment $18366 $2831 [33]
ASBO with non-operative treatment $2565 $299 [33]
Repeat surgery—no adhesions $14063 $812 [5]
Repeat surgery—adhesions $18579 $1722 [5]
HA/CMC hyaluronate carboxymethylcellulose, ASBO adhesive small bowel obstruction, SD standard deviation
*For the number of sheets per patient, a Beta-PERT distribution was assigned, ranging between 2 and 4
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6.6% (95% CI 5.2–8.1% ) to 4.5% (95% CI 2.2–9.2%) with
an adhesion barrier. Costs increased by $163 per patient
when an adhesion barrier was used. Direct health care
costs over 4 years after laparoscopic colorectal surgery
for the adhesion barrier group were $4482 (95% CI
$3031–$5591) versus $4320 (95% CI $2881–$5 709) for
the no adhesion barrier group.
Cost reduction for both open and laparoscopic colo-
rectal surgery is mainly due to the reduction of readmis-
sions for ASBO in the adhesion barrier arm. Reduction
of costs is also due to the prevention of adhesions at re-
operation and therefore reduction of operative time with
a decrease of time needed for adhesiolysis.
In open colorectal surgery, the adhesion barrier strat-
egy dominated the current, no-adhesion barrier practice.
For laparoscopic colorectal surgery, the ICER for one pa-
tient with adhesions prevented was $123.
Sensitivity analysis
The results of the probabilistic sensitivity analysis are
shown in Fig. 2a and b. The Monte Carlo simulation
showed that the use of an adhesion barrier is always
more effective in preventing adhesions and ASBO, for
both open and laparoscopic colorectal surgery. The use
of an adhesion barrier had a 66% probability of reducing
costs in the open surgery cohort. In the laparoscopic
surgery cohort, the probability was 41%.
Threshold analysis in the open colorectal surgery cohort
showed that using a barrier priced at $736 (95% CI
$305–$1187) or more no longer reduces costs. The same
effect was seen with the re-operation rate lowered to 16%
(95% CI 1 - 74%) or less. In the laparoscopic surgery co-
hort, the thresholds for cost-reduction with an adhesion
barrier were a price of $592 (95% CI $256–$954) and a re-
operation rate of 24% (95% CI 3–100%).
Results of the deterministic sensitivity analysis are
shown in Fig. 3a and b. Variation of the costs of the adhe-
sion barrier had the largest effect on the ICER for one pa-
tient with adhesions prevented in open and laparoscopic
surgery. In the best-case scenario, applying an adhesion
barrier in both open and laparoscopic colorectal surgery
reduces costs. In the worst-case scenario, the ICER for
one patient with adhesions prevented is $908 in the open
colorectal surgery patient cohort and $1663 in the laparo-
scopic colorectal surgery patient cohort, Table 3.
Discussion
The routine use of an adhesion barrier in open colorec-
tal surgery is cost-effective, considering a 4-year time
frame. Whilst in laparoscopic colorectal surgery, the ex-
penses are only $163 per patient, and the additional
costs for one patient with adhesions prevented are $123.
The findings in the present study are in agreement with
a comparable study, which demonstrated cost savings in
Table 3 Results of base case and deterministic sensitivity analyses in the open and laparoscopic surgery cohorts
Strategy Costs Percentage adhesions Percentage ASBO Costs per patient with adhesions prevented
Open cohort
Baseline
No barrier $4474 88.9% 8.6%
Barrier $4372 45.3% 5.8% Dominant
Best-case scenario
No barrier $4474 88.9% 8.6%
Barrier $4129 38.2% 3.0% Dominant
Worst-case scenario
No barrier $4474 88.9% 8.6%
Barrier $4789 54.2% 11.3% $908
Laparoscopic cohort
Baseline
No barrier $4179 62.3% 6.6%
Barrier $4220 31.8% 4.5% $135
Best-case scenario
No barrier $4179 62.3% 6.6%
Barrier $4016 26.8% 2.3% Dominant
Worst-case scenario
No barrier $4179 62.3% 6.6%
Barrier $4576 38.0% 8.7% $1663
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all types of open abdominal surgery and potential cost-ef-
fectiveness in major laparoscopy [35]. The present study
has the advantage that it concerns a homogenous group
of patients with a high risk of post-operative adhesion for-
mation. This well-defined population enhances the clinical
applicability of the results. In addition, more recent cost
data are used in the present model, of which the majority
were specifically for colorectal surgery. Costs are twice as
much for operative treatment of ASBO and for the adhe-
sion barrier compared to costs reported previously. A
comparable underestimation of costs for the adhesion bar-
rier and ASBO treatment was found in other cost-effect-
iveness reports from earlier this century [11, 12]. The
most important limitation of previous studies is the lack
of evidence on efficacy of adhesion barriers in reducing
adhesion-related complications.
The major strength of the present study is that the re-
cently generated evidence for the burden of adhesions
and the efficacy of adhesion barriers in colorectal sur-
gery could be synthesized. We synthesized all available
evidence to show the expected consequences of adopting
adhesion barriers on both costs and effects, as well as
the impact of the uncertainty due to a lack of evidence
regarding these consequences. A limitation is the need
to extrapolate data on the efficacy of adhesion barriers
from open to laparoscopic colorectal surgery, due to
scarce and inconsistent evidence with other formulas of
HA/CMC (e.g. slurry made of film and spray) in
Fig. 2 a Scatter plot of Monte Carlo simulation for open colorectal surgery, displaying cost (y-axis) and effect (x-axis) of adhesion barrier strategy.
b Scatter plot of Monte Carlo simulation for laparoscopic colorectal surgery, displaying cost (y-axis) and effect (x-axis) of adhesion barrier strategy
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laparoscopy [36–38]. A deviating efficacy in laparoscopy
would be highly relevant, particularly, because the ma-
jority of colorectal resections are currently performed by
laparoscopy [18]. In the worst-case scenario, assuming
reduced effectiveness of the adhesion barrier (RR 0.61)
resulted in an ICER of $908 in the open surgery cohort
and $1633 in the laparoscopic surgery cohort, which for
laparoscopy is more than a tenfold increase compared to
base case analysis. Therefore, the modelled risk ratio
(0.51) of adhesions with the use of an adhesion barrier
should serve as reference standard for the development
of novel adhesion barriers for laparoscopic use.
With the rise of laparoscopy in colorectal surgery,
open surgery is almost exclusively performed in cases
that are not suited for a laparoscopic approach. One of
the reasons for an open approach could be problems
with adhesions during laparoscopic surgery. Open cases
are therefore more prone to postoperative complications
[5]. This example illustrates the need for adhesion bar-
riers in both laparoscopic and open surgery, to prevent
future problems at repeat surgery.
The time frame, within which the model applies, was
limited to 4 years, whilst adhesion-related complications
or repeat surgery may occur many years later [13].
However, approximately 60% of ASBO occurs within
the first 4 years after lower abdominal surgery [13];
there is no data available for repeat surgery. Using a
longer time frame would increase ASBO and repeat
surgery rate, thereby potentially increasing the clinical
benefit and cost-effectiveness of the adhesion barrier
strategy.
Female infertility and chronic visceral pain, which are
known consequences of adhesions, were not included in
the model. Risk for infertility is only applicable to a
small group of female patients undergoing colorectal
surgeries at a young age. No consistent evidence is avail-
able regarding chronic visceral pain, and most costs are
generated outside the hospital [4]. The incompleteness
of the model for these adhesion-related complications
may have caused underestimation of adhesion-related
costs, and thus an underestimation of the cost-effective-
ness of the use of adhesion barriers.
The model took into account the costs of repeat sur-
gery depending on the presence of adhesions, and not
the extent and severity of adhesions. Evidence shows
that laparoscopic approach and use of an adhesion bar-
rier reduce the incidence of adhesions and their extent
and severity [8, 19]. Although reduction of extent and
Fig. 3 a Tornado diagram of variation of individual parameters in open colorectal surgery. b Tornado diagram of variation of individual
parameters in laparoscopic colorectal surgery
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severity of adhesions potentially decreases adhesiolysis-
related complications and costs, the evidence was insuf-
ficient to consider including these variables in the model
[5]. Excluding the efficacy and costs related to reduction
in severity and extent may have resulted in an overesti-
mation of the adhesion-related costs in the laparoscopic
surgery cohort and an underestimation of the benefit of
an adhesion barrier in both cohorts.
The costs of an adhesion barrier were based on the
unit costs in the Netherlands in 2016. The unit costs
may change according to the volume of products re-
quired. Variation of the costs of an adhesion barrier had
the largest influence in our model, Fig. 3a and b. Higher
volumes may result in a lower unit cost, favouring the
cost-effectiveness of the use of adhesion barriers in colo-
rectal surgery.
Due to a higher life expectancy and advances in surgi-
cal technology, an increasing number of patients
undergo abdominal surgery multiple times during their
lifetime [32]. Adhesion formation is the most common
long-term complication of abdominal surgery, and pre-
vention of adhesion formation from initial abdominal
surgery is the critical step in breaking the sequence of
complications due to adhesions. Despite evidence of re-
duced adhesion formation with the application of adhe-
sion barriers, adhesion barriers are seldom used in
practice. Doubts about cost-effectiveness and the need
for adhesion prevention in the ‘minimally invasive era’
probably underlie this reluctance [9]. The present cost-
effectiveness analysis is based on the best evidence avail-
able for both open and laparoscopic colorectal surgery
and can, for open colorectal surgery at least, remove
these doubts. Since the use of an adhesion barrier in lap-
aroscopic colorectal surgery involves extra costs, data on
quality-adjusted life-years (QALYs) are required to value
the benefits of adhesion barriers and to compare the
costs per unit of effect gained to a cost-effectiveness
threshold [39]. In order to determine QALYs for adhe-
sions and the use of adhesion barriers, future research
should address patient-reported outcomes (PROs), such
as functional status and quality of life. It is conceivable
that adhesion-related complications will have a negative
impact on PROs [40].
Conclusion
The use of an adhesion barrier in open colorectal sur-
gery will probably result in cost savings, and in laparo-
scopic colorectal surgery, this might be accompanied by
limited additional costs. For laparoscopic colorectal sur-
gery, more evidence on adhesion barriers is a prerequis-
ite for clinical implementation.
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